A detailed history of Prestige Wealth Management Group LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Prestige Wealth Management Group LLC holds 25 shares of ADPT stock, worth $142. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25
Previous 25 -0.0%
Holding current value
$142
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

SELL
$6.4 - $14.73 $428 - $986
-67 Reduced 72.83%
25 $0
Q2 2021

Aug 12, 2021

BUY
$32.22 - $44.59 $805 - $1,114
25 Added 37.31%
92 $4,000
Q4 2020

Feb 17, 2021

SELL
$45.01 - $65.47 $90 - $130
-2 Reduced 2.9%
67 $4,000
Q2 2020

Aug 13, 2020

BUY
$24.95 - $48.38 $1,047 - $2,031
42 Added 155.56%
69 $3,000
Q1 2020

May 15, 2020

BUY
$16.96 - $34.16 $457 - $922
27 New
27 $1,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $812M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Prestige Wealth Management Group LLC Portfolio

Follow Prestige Wealth Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prestige Wealth Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prestige Wealth Management Group LLC with notifications on news.